Traduction de «Dose to the abdomen » (Anglais → Français) :

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

prepare medication doses according to patient needs | ready doses of medication according to patient needs | prepare doses of medication according to patient needs | prepare doses of medication according to the needs of patients

The National dose registry of Canada: a report [ The National dose registry of Canada ]

survey radiography of the abdomen

external oblique muscle of the abdomen [ external oblique | musculus obliquus externus abdominis ]

measurement of the ambient dose equivalent rate [ ambient dose equivalent rate measurement ]

Symptoms and signs involving the digestive system and abdomen

Other symptoms and signs involving the digestive system and abdomen

5.4. A deviation of more than 50 % between the average reagent consumption and the average demanded reagent consumption by the engine system over a period of 30 minutes of vehicle operation, shall result in the activation of the driver warning system in section 3, which shall display a message indicating an appropriate warning (e.g. ‘urea dosing malfunction’, ‘AdBlue dosing malfunction’, or ‘reagent dosing malfunction’).

(3) If an equivalent dose that exceeds the applicable equivalent dose limit prescribed by section 14 or 15 is received by or committed to a person and the Commission or a designated officer authorized under paragraph 37(2)(h) of the Act authorizes the return to work of that person, the equivalent dose limit for the dosimetry period is the sum of the equivalent dose limit that was exceeded and the equivalent dose that was received by and committed to the person up to the time that the person was required to leave work in accordance with paragraph 16(b).

15 (1) During the control of an emergency and the consequent immediate and urgent remedial work, the effective dose and the equivalent dose may exceed the applicable dose limits prescribed by sections 13 and 14, but the effective dose shall not exceed 500 mSv and the equivalent dose received by the skin shall not exceed 5 000 mSv.

Return to footnote When the equivalent dose received by and committed to one of these remainder organs and tissues exceeds the equivalent dose received by and committed to any one of the organs and tissues listed in items 1 to 12, a weighting factor of 0.025 shall be applied to that remainder organ or tissue and a weighting factor of 0.025 shall be applied to the average equivalent dose received by and committed to the rest of the remainder organs and tissues.